Filed in archive
Diagnostics
, Studies
by Gloria Gamat on December 30, 2006

Developed by UCLA researchers, the compound called FDDNP can also be potentially used in evaluating new treatments for Alzheimer's.
FDDNP binds to plaques and tangles, allowing researchers to see these abnormal deposits in the brains of Alzheimer's disease patients on PET (positron emission tomography) scans.
According to Susan Molchan, M.D., program officer in the NIA Neuroscience and Neuropsychology of Aging Program:
"The hope is that better imaging techniques and markers will allow us to conduct clinical trials with fewer volunteers and in less time.
The ability to image brain changes may allow us to see how drugs affect the accumulation of proteins in the brain that cause Alzheimer's plaques and tangles, possibly preventing or delaying the progression of Alzheimer's."
Read the full report.
[Photo Credit: Science Museum]
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/47611
Mr Wong
Vote for FDDNP: New UCLA Imaging Compound for Early Alzheimer's Detection:
|
Rating: 9.00 out of 1 vote(s) cast.
|
Response from:
University Update
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









